21 CFR 516.28
§ 516.28 Publication of MUMS-drug designations.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 516.28, § 516.28 Publication of MUMS-drug designations, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87010
- Permanent ID
ys:prov:87010@1- SHA-256
381b832cb53b055994f6f48ead65cd4c15574c5a163f6f1486474811538030e5
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
FDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Dockets Management Staff, and will contain the following information for each MUMS-designated drug:
(a) The name and address of the sponsor;
(b) The established name and trade name, if any, of the drug;
(c) The dosage form of the drug;
(d) The species and the proposed intended use for which MUMS-drug designation was granted; and
(e) The date designation was granted.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.